BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 556 filers reported holding BIO-TECHNE CORP in Q3 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,070 | -15.0% | 15,716 | +1.9% | 0.00% | -33.3% |
| Q2 2023 | $1,259 | +4.7% | 15,418 | -5.0% | 0.00% | 0.0% |
| Q1 2023 | $1,203 | -39.9% | 16,228 | -32.9% | 0.00% | -40.0% |
| Q4 2022 | $2,003 | -99.9% | 24,174 | +289.5% | 0.01% | 0.0% |
| Q3 2022 | $1,762,000 | -14.4% | 6,206 | +4.5% | 0.01% | 0.0% |
| Q2 2022 | $2,058,000 | -12.3% | 5,937 | +9.6% | 0.01% | 0.0% |
| Q1 2022 | $2,346,000 | -16.9% | 5,418 | -0.7% | 0.01% | -16.7% |
| Q4 2021 | $2,823,000 | -34.3% | 5,458 | -38.4% | 0.01% | -45.5% |
| Q3 2021 | $4,296,000 | +76.4% | 8,866 | +63.9% | 0.01% | +83.3% |
| Q2 2021 | $2,435,000 | +8.7% | 5,408 | -7.8% | 0.01% | 0.0% |
| Q1 2021 | $2,241,000 | +28.1% | 5,868 | +6.4% | 0.01% | +20.0% |
| Q4 2020 | $1,750,000 | +3.1% | 5,513 | -19.5% | 0.01% | -16.7% |
| Q3 2020 | $1,697,000 | +49.1% | 6,850 | +58.9% | 0.01% | +50.0% |
| Q2 2020 | $1,138,000 | +32.6% | 4,312 | -4.7% | 0.00% | 0.0% |
| Q1 2020 | $858,000 | -14.2% | 4,527 | -0.6% | 0.00% | 0.0% |
| Q4 2019 | $1,000,000 | +11.1% | 4,556 | -1.0% | 0.00% | 0.0% |
| Q3 2019 | $900,000 | -0.8% | 4,600 | +5.6% | 0.00% | 0.0% |
| Q2 2019 | $907,000 | +19.0% | 4,354 | +13.4% | 0.00% | 0.0% |
| Q1 2019 | $762,000 | +42.7% | 3,841 | +4.1% | 0.00% | +33.3% |
| Q4 2018 | $534,000 | -27.9% | 3,690 | +1.6% | 0.00% | -25.0% |
| Q3 2018 | $741,000 | -52.1% | 3,632 | -65.3% | 0.00% | -50.0% |
| Q2 2018 | $1,547,000 | +156.1% | 10,456 | +161.4% | 0.01% | +166.7% |
| Q1 2018 | $604,000 | +16.8% | 4,000 | +0.2% | 0.00% | 0.0% |
| Q4 2017 | $517,000 | – | 3,993 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 46,500 | $16,119,000 | 8.75% |
| Montanaro Asset Management Ltd | 93,950 | $32,567,000 | 4.90% |
| Jackson Square Partners, LLC | 556,157 | $192,786,000 | 4.50% |
| STONE RUN CAPITAL, LLC | 22,405 | $7,767,000 | 3.91% |
| Ownership Capital B.V. | 655,654 | $227,276,000 | 3.90% |
| Brown Capital Management | 839,587 | $291,034,000 | 3.90% |
| Sandhill Capital Partners LLC | 97,382 | $33,757,000 | 3.61% |
| DF DENT & CO INC | 684,026 | $237,111,000 | 3.34% |
| Westwind Capital | 27,946 | $9,687,000 | 3.17% |
| MAIRS & POWER INC | 655,930 | $227,371,000 | 2.72% |